The effectiveness of the complex is determined by the presence of inosine, the second component increases its availability for lymphocytes. Groprinsin® blocks the multiplication of viral particles by damaging the genetic apparatus, stimulates macrophage activity, proliferation of lymphocytes and the formation of cytokines.
Reduces the clinical manifestations of viral diseases, accelerates convalescence, increases the resistance of the body.
When Gropronosin is prescribed as an auxiliary drug for infection of the mucous membranes and skin caused by the Herpes simplex virus, faster healing of the affected surface occurs than with conventional treatment. More rarely new vesicles, swelling, erosion and relapse of the disease. With the timely use of the drug, the incidence of viral infections decreases, the duration and severity of the disease decreases.
- immunodeficiency conditions caused by viral infections in patients with normal and weakened immune system, incl. diseases caused by Herpes simplex virus types 1 and 2 (including genital herpes and herpes of other localization
- subacute sclerosing panencephalitis
The active substance is inosine pranobex (Inosinum pranobexum).
1 tablet contains 500 mg of inosine pranobex (a complex containing inosine and 2-hydroxypropyl dimethyl ammonium 4-acetamidobenzoate in a molar ratio of 1: 3).
The drug is taken orally after meal, at regular intervals (8 or 6 no) 3-4 times / day.
Adults administered at a dose of 3-4 g (from 6 to 8 tab.)/d, razdelennoy of 3-4 admission.
Children aged 2 to 12 years administered at a dose of 50 mg / kg / day, razdelennoy of 3-4 admission.
In adults and children at serious infectious diseases the dose may be increased individually under medical supervision to 100 mg / kg / day 4-6 receptions.
The drug is usually applied for 5 days, sometimes longer, depending on the disease. After an 8-day break course of treatment can be repeated.
The tablets are, with a little water.
Development of possible adverse reactions in early treatment.
From the digestive system: decreased appetite, nausea, vomiting, diarrhea.
Other: a slight increase in the concentration of uric acid in blood and urine, allergic reactions.
- Urolithiasis disease
- Children up to age 2 years
- Lactation (breast-feeding)
- Hypersensitivity to the drug